Utah Medical Products, Inc. (FRA:UTM)

Market Cap	184.54M +14.5%
Revenue (ttm)	32.81M -5.8%
Net Income	9.61M -18.7%
EPS	2.97 -12.1%
Shares Out	n/a
PE Ratio	19.20
Forward PE	n/a
Dividend	1.05 (1.85%)
Ex-Dividend Date	Mar 17, 2026

Volume	n/a
Average Volume	n/a
Open	57.00
Previous Close	58.50
Day's Range	57.00 - 57.00
52-Week Range	44.60 - 60.50
Beta	n/a
RSI	58.84
Earnings Date	Jan 30, 2026

About Utah Medical Products

Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK fee...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1978
• Employees: 146
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: UTM

Financial Performance

In 2025, Utah Medical Products's revenue was $38.52 million, a decrease of -5.83% compared to the previous year's $40.90 million. Earnings were $11.29 million, a decrease of -18.65%.

Financial numbers in USD